Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1374-2019Class I

SOLOPATH Balloon Expandable TransFemoral System, Model Numbers STFI-1425, STFI-1435, STFI-1625, STFI-1635...

Terumo Medical Corp. / initiated 2019-04-26 / Terminated / root cause: design

Terumo Medical Corporation began a recall of SOLOPATH Balloon Expandable TransFemoral System, Model Numbers STFI-1425, STFI-1435, STFI-1625, STFI-1635, STFI-1825, STFI-1835, STFI-1925, STFI-1935... on . FDA classified it as Class I and gives the reason as "There is a potential for dislodgement of the tip from the outer diameter of the sheath resulting in a loss of the smooth transition from the surface of the tip to the outer surface of the expandable sheath". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-1374-2019
Classification
Class I
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Terumo Medical Corp.
Product
SOLOPATH Balloon Expandable TransFemoral System, Model Numbers STFI-1425, STFI-1435, STFI-1625, STFI-1635, STFI-1825, STFI-1835, STFI-1925, STFI-1935, STFI-2125, STFI-2135 Product Usage: The SoloPath Balloon Expandable TransFemoral Introducer System (STFI) and the SoloPath Re-Collapsible Access System are sterile, single use devices designed for low profile, large bore vessel access. Both SoloPath products are inserted percutaneously into the femoral artery, over a guidewire, and once expanded, provide a guide for catheters and/or devices introduced into the femoral/iliac arteries. The devices are designed such that surface friction is reduced during insertion while minimizing access trauma and vessel trauma throughout the procedure.
Product code
DYB Introducer, Catheter
Reason for recall
There is a potential for dislodgement of the tip from the outer diameter of the sheath resulting in a loss of the smooth transition from the surface of the tip to the outer surface of the expandable sheath.
Root cause tag
design
FDA root cause
Device Design
Action
Urgent Medical Device Recall letters dated 4/26/19 were sent to customers.
Quantity in commerce
2228
Distribution
The products were distributed US nationwide. The products were distributed to the following foreign countries: Australia, Belgium, Brazil, Canada, Portugal, Hong Kong, Peru, Singapore.
Product codes and lots
Lot Codes: UG22 UG28A UK02 VA20 VN17 UG22 UK26 VA25 VC15 VG22 VN30 UH29 VA05 VG07 VG26 UH29 VH21 VK29 UH29 UK30 UP20 VF31 WG13 WK30 UH28 UK26 UL28 VD09 VH31 VM19 WP12 UG22 UG22A UH27 UH27A UL14 VA19 VG22 VM24 VP13 WG13 WL28 UG22 UH29 UL14 UL28 UN16 UP20 VA13 VC15 VD09 VH28 VK21 VL06 VL28 VM24 VN21 WG13 XA30 UG22 UL14 UN28 VH27 WM31 UN28 VG02 VP07 WN07

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1374-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1374-2019Class ITerminatedVoluntary: Firm initiated
Z-1375-2019Class ITerminatedVoluntary: Firm initiated
Z-1376-2019Class ITerminatedVoluntary: Firm initiated